5.0
Dec 11, 2017
Current employee, more than 10 years
Houston, TX
Recommend
CEO approval
Business outlook
Pros
The comrade, benefits, potential for growth and advancement. Innovative advancement in the treatment of cancer.
Cons
The 2017 layoffs would be the con.